US$ 23.67
cigna glp-1 coverage dropping obesity drug for employees (CI) Cigna Arizona Weight Loss GLP-1
Description
Apitegromab (SRK-015), an investigational new drug developed by Scholar Rock, is a fully human IgG4 monoclonal antibody that specifically binds to human Pro-GDF8 or latent GDF8 without binding to mature GDF8 or other closely related growth factors

People are nuts about protein and likely beyond this claim, nobody cares what other nutritional attributes ...they're just "noise" (or a layered on health halo)

Learn how GLP-1 supports weight loss and type 2 diabetes, side effects, safety, and how IV therapy at River Oaks Drip Spa enhances energy and results.
PlexusDx offers personalized GLP-1 therapy tailored to your genetic profile and health goals

What the evidence shows: 1
